Abstract
Gray platelet syndrome (GPS) is an autosomal recessive bleeding disorder that is characterized by large platelets that lack α-granules. Here we show that mutations in NBEAL2 (neurobeachin-like 2), which encodes a BEACH/ARM/WD40 domain protein, cause GPS and that megakaryocytes and platelets from individuals with GPS express a unique combination of NBEAL2 transcripts. Proteomic analysis of sucrose-gradient subcellular fractions of platelets indicated that NBEAL2 localizes to the dense tubular system (endoplasmic reticulum) in platelets.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rendu, F. & Brohard-Bohn, B. Platelets 12, 261–273 (2001).
Maynard, D.M., Heijnen, H.F., Horne, M.K., White, J.G. & Gahl, W.A. J. Thromb. Haemost. 5, 1945–1955 (2007).
Weiss, H.J. et al. Blood 54, 1296–1319 (1979).
Gunay-Aygun, M., Huizing, M. & Gahl, W.A. Semin. Thromb. Hemost. 30, 537–547 (2004).
Nurden, A.T. & Nurden, P. Blood Rev. 21, 21–36 (2007).
Gunay-Aygun, M. et al. Blood 116, 4990–5001 (2010).
Raccuglia, G. Am. J. Med. 51, 818–828 (1971).
White, J.G. Am. J. Pathol. 95, 445–462 (1979).
Breton-Gorius, J., Vainchenker, W., Nurden, A., Levy-Toledano, S. & Caen, J. Am. J. Pathol. 102, 10–19 (1981).
Maynard, D.M., Heijnen, H.F., Gahl, W.A. & Gunay-Aygun, M. J. Thromb. Haemost. 8, 1786–1796 (2010).
Hyman, T. et al. Br. J. Haematol. 122, 142–149 (2003).
Jiang, F., Jia, Y. & Cohen, I. Blood 99, 3579–3584 (2002).
Malara, A. et al. Blood 117, 2476–2483 (2010).
Wang, N., Wu, W.I. & De Lozanne, A. J. Cell. Biochem. 86, 561–570 (2002).
Kaplan, J., De Domenico, I. & Ward, D.M. Curr. Opin. Hematol. 15, 22–29 (2008).
Acknowledgements
We thank all of our subjects with GPS and their families for their cooperation; the NIH Intramural Sequencing Center for performing the whole-exome sequencing and analysis; A. Nurden for the French patient; I. Bernardini and R. Fisher for technical assistance; H. Edwards, L. Riley, K. Patzel, P. Tanpaiboon, J. Chezar and J. Manaster for DNA sequencing assistance; T. Markello for the SNP array; and I. Maric, S. Gucer and I. Kuzu for assistance with bone marrow slides. This study was supported by the Intramural Research Programs of the National Human Genome Research Institute and the NIH Clinical Center and by the Israeli Ministry of Justice; Izvonot Fund, grants 84/2004, 85/2004 and 9090-25/2007 to T.C.F.-Z.
Author information
Authors and Affiliations
Contributions
M.G.-A. is the principal investigator of clinical trials NCT00069680 (Genetic Analysis of Gray Platelet Syndrome) and NCT00086476 (Investigations of Megakaryocytes from Patients with Abnormal Platelet Vesicles); M.G.-A. wrote the manuscript and cultured megakaryocytes; M.G.-A., W.A.G. and T.C.F.-Z. designed and supervised research; M.G.-A., T.C.F.-Z. and T.V. analyzed clinical and molecular data; T.C.F.-Z., is the principal investigator of the Israeli protocol 'Clinical and Genetic Analysis of Gray Platelet Syndrome'; W.A.G. is the principal investigator of clinical trial NCT00369421 (Diagnosis and Treatment of Patients With Inborn Errors of Metabolism) and accountable investigator of clinical trial NCT00069680 (Genetic Analysis of Gray Platelet Syndrome); M.G.-A., T.V., T.C.F.-Z., J.C.M., C.F.B. and M.H. supervised DNA sequencing; M.G.-A., T.V., Y.Z.-E., F.G., M.C., M.K., C.F.B., N.K., Y.H., K.B., R.K. and P.C., performed DNA sequencing; M.G.-A., T.C.F.-Z., F.G., M.C., M.K., N.K., R.K., Y.A., M.A., A.S.F., B.E.K., K.J. and J.G.W. recruited patients and provided clinical data; J.G.W. performed electron microscopy; D.M. performed proteomic analysis; H.D. cultured fibroblasts; T.C.F.-Z., T.V., Y.Z.-E., F.G., M.C., M.K., C.F.B., N.K., Y.H., D.M., H.D., K.B., R.K., Y.A., M.A., A.S.F., B.E.K., K.J., P.C., J.C.M., J.G.W., M.H. and W.A.G. participated in preparing the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–4, Supplementary Table 1 and Supplementary Methods (PDF 2002 kb)
Rights and permissions
About this article
Cite this article
Gunay-Aygun, M., Falik-Zaccai, T., Vilboux, T. et al. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules. Nat Genet 43, 732–734 (2011). https://doi.org/10.1038/ng.883
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.883